Nov 08, 2023 / 06:00PM GMT
Ashwani Verma - UBS Investment Bank, Research Division - Director of Americas Equity Research & US Specialty Pharma Analyst
All right. Good day, everybody. My name is Ash Verma. Welcome to UBS Biopharma Conference in Miami. Our next company on the stage is Cytokinetics. And with me, we have Andrew Callos, who will be Chief Commercial Officer; and Fady Malik, who is the EVP of R&D. How are you guys doing today?
Fady Ibraham Malik - Cytokinetics, Incorporated - EVP of Research & Development
Doing well.
Questions and Answers:
Ashwani Verma - UBS Investment Bank, Research Division - Director of Americas Equity Research & US Specialty Pharma AnalystGreat. Thanks for joining us. So since Andrew, you're sitting next to me, so maybe I can start off with some commercial questions first. And I guess maybe just to preface that, like it will be helpful to get a little bit of a background about the story. So if you can just give us a high-level outline for people who might not be familiar about Cytokinetics,
Trustpilot
